Diploma PLC (LON:DPLM – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is GBX 6,251.25.
A number of analysts have recently commented on the company. JPMorgan Chase & Co. upped their price objective on Diploma from GBX 5,120 to GBX 5,760 and gave the stock a “neutral” rating in a report on Friday. Stifel Nicolaus lifted their target price on Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a report on Thursday, March 19th. Deutsche Bank Aktiengesellschaft upped their price target on Diploma from GBX 6,200 to GBX 6,400 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Shore Capital Group restated a “hold” rating on shares of Diploma in a report on Wednesday, March 18th. Finally, Jefferies Financial Group lifted their price objective on Diploma from GBX 5,200 to GBX 5,700 and gave the company a “hold” rating in a research note on Monday, March 23rd.
Read Our Latest Stock Report on DPLM
Insider Activity at Diploma
Diploma Stock Performance
LON:DPLM opened at GBX 5,835.14 on Friday. The company has a market cap of £7.82 billion, a P/E ratio of 42.50, a P/E/G ratio of 2.82 and a beta of 1.03. The firm’s 50 day moving average is GBX 5,483.27 and its two-hundred day moving average is GBX 5,442.46. Diploma has a fifty-two week low of GBX 3,532 and a fifty-two week high of GBX 6,019.52. The company has a quick ratio of 0.80, a current ratio of 2.04 and a debt-to-equity ratio of 46.97.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
